With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|MTG-16 Regulation by Phosphorylation||Vanderbilt University Medical Center / Michael Engel, MD, PhD||Young Investigator Grants||2006||Tennessee|
|Mediators of Metastasis in Alveolar Rhabdomyosarcoma.||University of Texas Health Science Center at San Antonio / Koichi Nishijo, MD, PhD||Young Investigator Grants||2006||Texas|
|Hedgehog & IGF Signaling through IRSI in Brain Development and Medulloblastoma||Memorial Sloan-Kettering Cancer Center / Anna Marie Kenney, PhD||Young Investigator Grants||2006||New York|
|New Approaches to Neuroblastoma Therapy (NANT) Consortium||Children's Hospital Los Angeles / Robert Seeger, MD||Phase I/II Infrastructure Grants||2006||California|
|Mechanisms of leukocyte recruitment to the lung during idiopathic pneumonia syndrome following allogeneic bone marrow transplantation.||Regents of the University of Michigan / Sung Won Choi, MD||Young Investigator Grants||2006||Michigan|
|Pediatric Oncology Translational Research Program.||Vanderbilt University Medical Center / James Whitlock, MD||Phase I/II Infrastructure Grants||2006||Tennessee|
|WIP1 Modulates Responsiveness of MB to Genotoxic Stress.||Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta / Robert Craig Castellino, MD||Young Investigator Grants||2006||Georgia|
|Building a Texas-based center for neuroblastoma clinical research.||Baylor College of Medicine / Heidi Russell, MD||Phase I/II Infrastructure Grants||2006||Texas|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|
|Expanding Access to New Agents for Cancer Treatment.||Children's Hospital Colorado / Lia Gore, MD||Phase I/II Infrastructure Grants||2006||Colorado|